Nuvilex, Inc. Moves Closer to Head to Head With Eli Lilly in Phase III Clinical Trials
July 25, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 25, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is currently preparing the way to challenge Eli Lilly's blockbuster cancer drug, Gemzar, and doing so with the knowledge...
Nuvilex, Inc. Acquisition Could Be Steal of the Century and Worth Billions
July 18, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 18, 2013) - In a recently announced acquisition deal, Nuvilex, Inc. (OTCQB: NVLX), pulled off what can only be described as the steal of the century. The company...
Nuvilex, Inc. Returns 100 Million Shares to Company's Treasury After Completing Acquisition
July 16, 2013 09:30 ET
|
Nuvilex, Inc.
SILVER SPRING, MD--(Marketwired - Jul 16, 2013) - Nuvilex, Inc. (OTCQB: NVLX), (the "Company"), an international biotechnology company and provider of natural products and cell and gene therapy...
Nuvilex, Inc., Johnson & Johnson, and Medtronic, Inc., All Developing Type of Artificial Pancreas for Diabetics
July 02, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jul 2, 2013) - While Medtronic, Inc. and Johnson & Johnson are developing devices that can essentially act as a type of "artificial pancreas," Nuvilex, Inc.'s...
Nuvilex, Inc. a Biotech Developing Treatments for Healthcare's Hard Targets
June 26, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jun 26, 2013) - Nuvilex, Inc. (OTCQB: NVLX) executives aren't daunted by the statistics. As a matter of fact, they're aware the research they do is directed...
Nuvilex, Inc. Could Become Significant Player in the Oncology Arena With Successful Phase III Trials
May 22, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 22, 2013) - Nuvilex, Inc. (OTCQB: NVLX) is a diamond in the rough in the truest sense. Currently shares of the Silver Spring, Maryland, biotechnology firm can...
Nuvilex, Inc. and Celgene, Corp. Can Both Replace Eli Lilly's Cancer Drug Gemzar
May 20, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 20, 2013) - The race is on, and patients with advanced stage, inoperable pancreatic cancer will be the recipients of the winner's treatment. Two biotechnology...
Nuvilex, Inc. Cell Encapsulation Could Mimic Combination Chemotherapy
May 15, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 15, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has had its living cell encapsulation or "Cell-in-a-Box" technology tested again and again, and each time it has proven it...
Nuvilex, Inc. Pancreatic Cancer Therapy Offers Higher Survival Rate and Less Toxicity Than Competitors
May 02, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - May 2, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has already produced impressive results from its two independent Phase II clinical trials in patients with advanced,...
Nuvilex, Inc. Pancreatic Cancer Trials Could Make "Cell-in-a-Box" Gold Standard
April 29, 2013 08:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Apr 29, 2013) - While many biotech and pharmaceutical companies are designing one drug after another to address specific health problems, Nuvilex, Inc. (OTCQB: NVLX) is...